Menu
Affinity Biologicals, Inc.
  • HOME
  • ABOUT US
    • Upcoming Meetings
  • PRODUCTS
    • Antibodies
    • Matched-Pair Antibody Sets
    • Complete ELISA Kits
      • Factor VII ELISA Kit
      • Factor VIII ELISA Kit
      • Factor VIII PLUS ELISA Kit
      • Factor IX ELISA Kit
      • Factor X ELISA Kit
      • Factor XI ELISA Kit
      • TAFI ELISA Kit
    • Deficient Plasmas
      • Frozen – Research
      • Lyophilized – Research
      • Frozen – Diagnostic
    • Control Plasma – Diagnostic
      • Frozen Calibrator – Reference Plasma
      • Frozen Normal Controls
      • Frozen Abnormal Controls
      • Multi-Level Controls
      • Low Fibrinogen Control Plasma
    • Factor Inhibitor Plasmas
    • Normal Donor Plasma Set
    • Custom Human Plasma
  • SERVICES
    • Custom Polyclonal Antibody Production
    • Contract Manufacturing
    • Specialty Disease State Plasmas & Hemostasis Controls
    • Custom Protein Purification
  • TECHNICAL
    • FAQ – Frequently Asked Questions
    • ELISA and Immunoblotting Methods
    • Species Cross Reactivity
    • Polyclonal Antibody Formats
    • Antibody Applications
    • Antibody Concentration Ranges
    • Antibody Storage – Handling Recommendations
  • SDS – Product Safety Data Sheets
  • ORDERING
    • How to Order
    • Find a Distributor
    • Quote Request Form
  • CONTACT
    • How to Find Us
    • Contact Form
Close Menu
Home / Product Family / TAFI - Thrombin Activatable Fibrinolysis Inhibitor Products / TAFI Deficient – Depleted Plasma

TAFI Deficient – Depleted Plasma

TAFI-DP – Frozen TAFI Deficient Plasma – 1ml or bulk quantities
TAFI-LDP – Lyophilized TAFI Deficient Plasma – 1ml

This product is currently out of stock and unavailable.

SKU: N/A Categories: Deficient Plasma, TAFI Deficient Plasma, TAFI - Thrombin Activatable Fibrinolysis Inhibitor Products Tags: Deficient Plasma, Depleted Plasma, Products, TAFI - Thrombin Activatable Fibrinolysis Inhibitor, Plasma

Description

TAFI Deficient – Depleted Plasma

TAFI Deficient – Depleted Plasma is manufactured from normal citrated human plasma that has been depleted of TAFI Deficient – Depleted Plasma by selective affinity immuno-adsorption using antibodies directed towards TAFI.  Available in two different formats – Frozen and Lyophilized

Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material.  Our TAFI Deficient – Depleted Plasma can be used for further manufacturing or research use only applications.


Frozen TAFI Deficient Plasma

Product Code:  TAFI-DP

Presentation:  Frozen TAFI Deficient – Depleted Plasma

Preparation/Handling:  Thaw 1 ml vials in 37oC water bath for 5 minutes; for bulk volumes, thawing time will be dependent on bottle size.

Storage and Stability:  Plasma is shipped frozen and should be stored below -60oC. Product is stable until date stated on vial label when stored at -60oC. Once thawed, plasma is stable for 4 hours at 2-8oC in original vial.

Certificate of Analysis:  available upon request

Lyophilized TAFI Deficient Plasma

Product Code:  TAFI-LDP

Presentation:  Freeze Dried TAFI Deficient – Depleted Plasma containing 50 mM HEPES and stabilizers.

Reconstitution: Reconstitute with 1 mL of reagent grade water.  Allow contents to dissolve for 15 minutes at room temperature with occasional swirling.  Stability after reconstitution is 4 hours at ambient (18-25oC), or 30 days at –20oC.

Storage and Stability:  Prior to reconstitution, dried plasma should be stored at 2-8°C.  Product is stable until date stated on vial label when stored at 2-8oC.  Stability after reconstitution is 4 hours at ambient (18-25oC), or 30 days at –20oC.

Certificate of Analysis:  available upon request


Description of Thrombin Activatible Fibrinolysis Inhibitor (TAFI)

TAFI (Thrombin Activatable Fibrinolysis Inhibitor), also referred to as plasma procarboxypeptidase-B, procarboxypeptidase-U and R, circulates in plasma as a zymogen with a mass of 58,000 daltons (1-6). Proteolytic activation of TAFI yields an N-terminally derived activation peptide and the C-terminal portion corresponding to the metalloprotease, activated TAFI (TAFIa). TAFIa exhibits exopeptidase activity with carboxypeptidase B-like substrate specificity capable of catalyzing the hydrolysis of C-terminal lysine and arginine residues. Cleavage of these residues on fibrin by TAFIa attenuates clot lysis by inhibiting the formation of the ternary activation complex comprising fibrin cofactor, tPA and plasminogen, thereby inhibiting plasmin generation. Although TAFI can be activated by various proteases including thrombin and plasmin, the physiological activator is proposed to be the complex thrombin-thrombomodulin since the rate of activation is stimulated 1250-fold compared to thrombin alone (4). However, the rate of TAFI activation is highly dependent upon its plasma concentration. Since TAFIa apparently plays a key role in connecting coagulation and fibrinolysis and significantly increases clot stability, determination of plasma concentration of TAFI is likely crucial to assess its subsequent potential antifibrinolytic effects1-6.

References and Review

  1. Eaton, D.L., Malloy, B.E., Tsai, S.P., Henzel, W., Drayna, D., Isolation, Molecular Cloning and Partial Characterization of a Novel Carboxypeptidase B from Human Plasma. J.Biol.Chem. 266:21833-21838, 1991.
  2. Hendriks, D., Scharpe, S., van Sande, M., Lommaert, M.P., Characterization of a carboxypeptidase in human serum distinct from carboxypeptidase N. J.Clin.Chem.Clin.BioChem. 27:277-285, 1989.
  3. Campbell, W., Okada, J. An Arginine specific carboxypeptidase generated in blood during coagulation of inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem.Biophys.Res.Commun. 162:933-939, 1989.
  4. Bajzar, L., Morser, J., Nesheim, M.E. TAFI, or procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J.Biol.Chem. 271:16603-16608, 1996.
  5. Mosnier, L.O., von Dem Borne, P.A. Meijers, J.C., Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb.Haemost. 80:829-835, 1998.
  6. Juhan-Vague, I., Renucci, J.F., and Grimaux, M., Morange, P.E., Gouvernet, J., Gourmelin, Y., Laessi, M.C. Thrombin Activatable Fibrinolysis Inhibitor Antigen Levels and cardiovascular Risk Factors. Arter.Thromb.Vascular.Biology. 20:2156-2161, 2000.

Related Products:

  • Fibrinogen, Prothrombin, Thrombin, Factor II, V, VII, VIII, IX, X, XI, XII, XII, XIII, Tissue Factor, vWF, PK, KN, Protein C, S, Z, Plasminogen, tPA, TAFI, ATIII, HCII, PAI-1, A2AP, PCI, A1AT, A2M, C1 INH, Elastase, B2GP1, APOH, Vitronectin, Vimentin, Platelet Factor 4, Platelet glycoprotein 2b/3A

    TAFI – Thrombin Activatable Fibrinolysis Inhibitor Polyclonal Antibody – HRP Conjugated

    SATAFI-HRP – Sheep anti human TAFI – Thrombin Activatable Fibrinolysis Inhibitor, peroxidase conjugated IgG (0.2 mg vial)

  • Fibrinogen, Prothrombin, Thrombin, Factor II, V, VII, VIII, IX, X, XI, XII, XII, XIII, Tissue Factor, vWF, PK, KN, Protein C, S, Z, Plasminogen, tPA, TAFI, ATIII, HCII, PAI-1, A2AP, PCI, A1AT, A2M, C1 INH, Elastase, B2GP1, APOH, Vitronectin, Vimentin, Platelet Factor 4, Platelet glycoprotein 2b/3A

    TAFI – Thrombin Activatable Fibrinolysis Inhibitor Polyclonal Antibody – Affinity Purified

    SATAFI-AP – Sheep anti human TAFI – Thrombin Activatable Fibrinolysis Inhibitor, affinity purified IgG (0.5 mg vial)

  • frozen-and-lyophilized-FDP

    TAFI Deficient – Depleted Plasma

    TAFI-DP – Frozen TAFI Deficient Plasma – 1ml or bulk quantities
    TAFI-LDP – Lyophilized TAFI Deficient Plasma – 1ml

  • FVIII ELISA Kit

    TAFI Antigen ELISA Kit

    TAFI-AG – Complete TAFI Antigen ELISA Kit – 1 plate/kit

SEARCH

Deficient Plasmas

  • Fibrinogen Deficient Plasma
  • Prothrombin-Factor II Deficient Plasma
  • Factor V Deficient Plasma
  • Factor VII Deficient Plasma
  • Factor VIII Deficient Plasma
  • vWF Deficient Plasma
  • vWF Deficient Plasma
  • Factor IX Deficient Plasma
  • Factor X Deficient Plasma
  • Factor XI Deficient Plasma
  • Factor XII Deficient Plasma
  • Factor XIII Deficient Plasma
  • alpha-2-Antiplasmin Deficient Plasma
  • Antithrombin – Heparin Cofactor II Deficient Plasma
  • Antithrombin – ATIII Deficient Plasma
  • Beta-2-Glycoprotein-1 APOH Deficient Plasma
  • Heparin Cofactor II Deficient Plasma
  • Protein C Deficient Plasma
  • Protein S Deficient Plasma
  • Protein C Inhibitor Deficient Plasma
  • TAFI Deficient Plasma
  • TAFI Deficient Plasma
  • Plasminogen Deficient Plasma
  • Prekallikrein Deficient Plasma
  • Kininogen Deficient Plasma
  • PAI-1 Deficient Plasma
  • tPA Deficient Plasma
  • tPA Deficient Plasma
  • Factor II Inhibitor Plasma
  • Factor IX Inhibitor Plasma
  • Factor V Inhibitor Plasma
  • Factor VII Inhibitor Plasma
  • Factor VIII Inhibitor Plasma
  • Factor X Inhibitor Plasma
  • Factor XI Inhibitor Plasma
  • Factor XII Inhibitor Plasma
Affinity Biologicals, Inc.
+1-905-304-9896
+1-800-903-6020Can/US
info@affinitybiologicals.com
1348 Sandhill Drive
Ancaster, ON
L9G 4V5

Privacy Statement
Sitemap
Terms and Conditions